Scholarly Index
James R. Berenson
Institute for Myeloma & Bone Cancer Research; 21,471 total citations; 513 total publications; best world rank #93
Institute for Myeloma & Bone Cancer Research
21,471Total citations
513Total publications
70H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 93 | US 51 | 99.35 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 140 | US 76 | 98.95 |
| Peptidase Inhibition and Analysis | Lifetime | 230 | US 108 | 98.99 |
| Bone health and treatments | Lifetime | 141 | US 71 | 99.19 |
| Protein Degradation and Inhibitors | Lifetime | 127 | US 77 | 98.91 |
| Cancer Treatment and Pharmacology | Lifetime | 864 | US 421 | 97.72 |
| Ubiquitin and proteasome pathways | Lifetime | 743 | US 374 | 97.01 |
| Medical Imaging and Pathology Studies | Lifetime | 679 | US 312 | 96.77 |
| Bone and Joint Diseases | Lifetime | 406 | US 166 | 96.81 |
| Histone Deacetylase Inhibitors Research | Lifetime | 609 | US 295 | 94.85 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 557 | US 237 | 96.18 |
| Natural Compounds in Disease Treatment | Lifetime | 453 | US 53 | 75.84 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 595 | US 277 | 92.27 |
| Protein Degradation and Inhibitors | 2021-2025 | 902 | US 377 | 85.24 |